CWRU scientists demystify protein at root of arthritis

July 24, 2002

CLEVELAND- Researchers at Case Western Reserve University have discovered kinks in aggrecan, a widely studied protein at the submolecular root of arthritis, a finding that brings scientists closer toward new drugs and other interventions to prevent or alleviate the disease.

"Aggrecan acts to organize and densely pack sugar molecules that give cartilage its resilience," said Steven Eppell, an assistant professor of biomedical engineering and director of the Nanoscale Orthopedic Biomaterials Laboratory at CWRU. "Our research shows that aggrecan is sharply bent in specific places and more flexible in other regions, and that the kinked areas may be more susceptible to the enzymes that degrade cartilage in osteoarthritis."

Eppell worked with Brian A. Todd and Jayan Rammohan, graduate students in the CWRU department of biomedical engineering, using funding from the National Institute for Arthritis and Musculoskeletal Research. The researchers examined the protein structure using an atomic force microscope in the Center for Cardiovascular Biomaterials at CWRU. Using sophisticated image processing, the team mapped images of aggrecan onto the human genome and discovered that the kinks in their images lined up with places where aggrecan gets degraded in osteoarthritis. The result provides a link between aggrecan's structure and its function in health and disease.

"Clarifying the functions of more than 30,000 proteins that make up the proteome is a major challenge in the wake of the human genome project," Eppell said. "Studying human proteins and discovering how they interact inside their microscopic three dimensional world is a path leading scientists closer to linking a disease with its genetic characteristics. Trailblazing these paths requires us to investigate these proteins, one at a time, to learn how they interact inside their own three-dimensional world and in the body."

According to the National Institutes of Health, osteoarthritis is the most common type of arthritis, especially among older people. The disease causes joint pain and limited movement because the surface layer of cartilage breaks down and wears away and allows bones under the cartilage to rub together, causing pain, swelling and loss of motion of the joint. Currently there is no well-accepted theory for what causes this disease.

"We are working vigorously to link the biological and mechanical properties of cartilage with its molecular structure," Eppell said. "Ultimately, we are in search of clues that lead to intelligent drug design and other interventions to prevent or alleviate arthritis."
-end-
Note : Images available at www.cwru.edu/pubaff/univcomm/2002/7-02/arthritis.htm

Case Western Reserve University

Related Arthritis Articles from Brightsurf:

Physical activity and sleep in adults with arthritis
A new study published in Arthritis Care & Research has examined patterns of 24-hour physical activity and sleep among patients with rheumatoid arthritis, lupus, and knee osteoarthritis.

Is rheumatoid arthritis two different diseases?
While disease activity improves over time for most rheumatoid arthritis (RA) patients, long-term outcomes only improve in RA patients with autoantibodies, according to a new study published this week in PLOS Medicine by Xanthe Matthijssen of Leiden University Medical Center, Netherlands, and colleagues.

Does the Mediterranean diet protect against rheumatoid arthritis?
Previous research has demonstrated a variety of health benefits associated with the Mediterranean diet, which is rich in olive oil, cereals, fruit and vegetables, fish, and a moderate amount of dairy, meat, and wine.

Reducing corticosteroid use in rheumatoid arthritis
Is the long-term use of glucocorticoids essential in people with chronic inflammatory diseases such as rheumatoid arthritis, or can early discontinuation prevent characteristic side effects?

Psoriasis onset determines if psoriatic arthritis patients develop arthritis or psoriasis first
In a new study presented at the 2019 ACR/ARP Annual Meeting, researchers found the age of psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis.

The ACR and the Arthritis Foundation present new guidelines offering therapeutic approaches and treatment options for juvenile idiopathic arthritis
Today, the American College of Rheumatology (ACR), in partnership with the Arthritis Foundation (AF), released two guidelines on juvenile idiopathic arthritis (JIA).

Does alcohol consumption have an effect on arthritis?
Several previous studies have demonstrated that moderate alcohol consumption is linked with less severe disease and better quality of life in patients with rheumatoid arthritis, but a new Arthritis Care & Research study suggests that this might not be because drinking alcohol is beneficial.

Prospect of a new treatment for rheumatoid arthritis
An international research group led by Charité -- Universitätsmedizin Berlin has completed testing a new drug to treat rheumatoid arthritis.

Can rare lymphocytes combat rheumatoid arthritis?
Immunologists at Friedrich-Alexander-Universität Erlangen-Nürnberg have demonstrated that ILC2, a group of rare lymphoid cells, play a key role in the development of inflammatory arthritis.

Which pain medication is safest for arthritis patients?
In a recent Alimentary Pharmacology & Therapeutics study, arthritis patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) for pain plus a stomach acid-reducing medicine called esomeprazole had infrequent gastrointestinal side effects.

Read More: Arthritis News and Arthritis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.